Method for separating and determining calcium levofolinate intermediate Z2 and related impurities thereof

Through the gradient elution technology of HPLC method, the calcium levofoliate intermediate Z2 and its impurities were successfully isolated and detected, solving the problem that the existing technology cannot be effectively separated and detected, and achieving high-efficiency and low detection limit drug quality control.

CN118914385APending Publication Date: 2024-11-08CHONGQING HUAPONT PHARMA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410924831.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-10
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

The prior art cannot effectively separate and detect impurities Z1, impurities A, impurities Z2b and levocene calcium levocene intermediate Z2, affecting drug quality control.

Method used

Using HPLC method, octadecylsilane bonded silica gel was used as the chromatographic column filler, and the calcium levofoliate intermediate Z2 and its impurities were separated by gradient elution. Mobile phase A was phosphate buffer solution, and mobile phase B was methanol. , the separation and quantitative detection of impurities are achieved through gradient elution procedures.

Benefits of technology

Effective separation and quantitative detection of calcium levofolic acid intermediate Z2 and its impurities is achieved, with low detection limit and high sensitivity, and separation can be completed within 50 minutes to ensure the controllability of drug quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914385A_ABST
    Figure CN118914385A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of analytical chemistry, and particularly relates to a method for separating and determining a calcium levofolinate intermediate Z2 and related impurities thereof. According to the method, high performance liquid chromatography is adopted for separation, qualitative detection and quantitative detection, octadecylsilane chemically bonded silica is adopted as a filler of a chromatographic column, a phosphate buffer solution is adopted as a mobile phase A, and methanol is adopted as a mobile phase B; separating the calcium levofolinate intermediate Z2 and related impurities thereof through gradient elution, and detecting in a detector to obtain a chromatogram; and calculating the content of each impurity by adopting an area normalization method. The method is simple to operate, strong in specificity, high in sensitivity and good in durability, and has important significance on quality control of calcium levofolinate.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of analytical chemistry, and in particular relates to a method for separating and determining a calcium folinate intermediate Z2 and related impurities thereof. Background Art

[0002] Calcium folinate intermediate Z2 is a key intermediate in the synthesis of calcium folinate. Its scientific name is (6aR)-3-amino-8-[4-[[(2S)-1,3-dicarboxypropyl]carbamoyl]phenyl]-1-oxo-2,5,6,6a,7,8-octahydro-1H-imidazo[1,5-f]pteridine-10-chloride, and its molecular formula is C 20 H 22 ClN7O6; molecular weight is 528.35; structural formula is shown in Formula Ⅰ.

[0003]

[0004] Studies have shown that impurities Z1, impurity A, and impurity Z may exist in the calcium folinate intermediate Z2. 2b , calcium folinate and other impurities, the structural formula of calcium folinate is shown in Formula II, the structural formula of impurity Z1 is shown in Formula III, the structural formula of impurity A is shown in Formula IV, and the impurity Z 2b The structural formula of is shown in Formula V.

[0005]

[0006] Impurity A is a pharmacopoeial impurity and is controlled in each reaction step to investigate its elimination in each step. 2b Aromatic amine with a warning structure is a base-toxic impurity. In the process of synthesizing Z2 from intermediate Z1, the impurity Z 1b The byproduct generated by the reaction of (a warning structure aromatic amine, whose structural formula is shown in Formula VI) with formic acid is impurity Z 2b , which is a process impurity; and Z2 hydrolysis also produces impurity Z 2b Because impurity Z 1b The intermediate Z1 has a high level (the control limit is not more than 0.2%), and Z2 is hydrolyzed to produce Z 2b , so it is necessary to track its subsequent byproduct Z 2b The formation of impurities Z 2b Impurity E (a statutory impurity in the EP Pharmacopoeia, with a control limit of no more than 0.3%) is finally generated in the finished product.

[0007]

[0008] Some prior art discloses methods for analyzing related substances in calcium folinate or its intermediates, such as CN114324618A patent discloses a method for separating and detecting calcium folinate intermediates and related substances. The chromatographic column used in the invention is filled with octyl bonded silica gel, and ammonium acetate buffer solution and organic solution are used for gradient elution to separate calcium folinate intermediates and related substances. CN102841169B patent discloses a method for determining calcium folinate related substances by high performance liquid chromatography gradient method, which uses octadecylsilane bonded silica gel as filler, phosphate buffer as mobile phase A, and phosphate buffer-methanol as mobile phase B, and separates and detects (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid, (2S)-2-[[4-[[(2-amino-4 -oxo-1,4-dihydro-6-pteridinyl)methyl]amino]benzoyl]amino]glutaric acid, (2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydro-6-pteridinyl)methyl]formamido]benzoyl]amino]glutaric acid and 2S)-2-[[4-[[(2-amino-4-oxo-1,4,7,8-tetrahydro-6-pteridinyl)methyl]amino]benzoyl]amino]glutaric acid. However, these methods cannot achieve the impurities Z1, impurities A, impurities Z in the calcium folinate intermediate Z2. 2b , effective detection of left calcium folinate.

[0009] Therefore, it is urgent to find a new method to achieve the impurities Z1, impurity A, impurity Z in the calcium folinate intermediate Z2. 2b , the separation and detection of calcium folinate, which is of great significance to the quality control of calcium folinate drugs. Summary of the invention

[0010] In view of this, one of the objects of the present invention is to provide a method for separating a calcium folinate intermediate Z2 and its impurities by HPLC, which method can achieve effective separation of the calcium folinate intermediate Z2 and its impurities in a time greater than 50 minutes or within 50 minutes, and provide support for the subsequent qualitative and quantitative analysis of the calcium folinate intermediate Z2 and its impurities.

[0011] To achieve the above object, the present invention adopts the following technical solutions:

[0012] A method for separating a calcium folinate intermediate Z2 and its impurities by HPLC, wherein the impurities include impurity A, impurity Z1, impurity Z2, impurity Z3, impurity Z4, impurity Z5, impurity Z6, impurity Z7, impurity Z8, impurity Z9, impurity Z10, impurity Z11, impurity Z12, impurity Z13, impurity Z14, impurity Z15 2b , calcium folinate; the chromatographic column of the HPLC method uses octadecylsilane bonded silica gel as a filler, the mobile phase includes a mobile phase A and a mobile phase B, the mobile phase A is a phosphate buffer, and the mobile phase B is methanol; impurities A, impurities Z1, impurities Z2, impurities Z3, impurities Z4, impurities Z5, impurities Z6, impurities Z7, impurities Z8, impurities Z9, impurities Z10, impurities Z11, impurities Z12, impurities Z13, impurities Z14, impurities Z15, impurities Z16, impurities Z17, impurities Z18, impurities Z29, impurities Z21, impurities Z21, impurities Z20, impurities Z21, impurities Z30, impurities Z40, impurities Z50, impurities Z60, impurities2b , separating the left calcium folinate intermediate Z2 and / or left calcium folinate;

[0013] The structural formula of the calcium folinate intermediate Z2 is shown in Formula I, the structural formula of the calcium folinate is shown in Formula II, the structural formula of the impurity Z1 is shown in Formula III, the structural formula of the impurity A is shown in Formula IV, and the impurity Z 2b The structural formula is shown in Formula V;

[0014]

[0015] Furthermore, the order in which the components are eluted is: impurity A, impurity Z1, impurity Z 2b , calcium folinate intermediate Z2, calcium folinate.

[0016] Further, the procedure of the gradient elution is as follows:

[0017] 0 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2;

[0018] 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2;

[0019] 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85-95:15-5;

[0020] 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85-95:15-5;

[0021] 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 80-90:20-10;

[0022] 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2;

[0023] 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2.

[0024] Preferably, the procedure of the gradient elution is as follows:

[0025] 0 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0026] 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0027] 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0028] 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0029] 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85:15;

[0030] 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0031] 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5.

[0032] Most preferably, the procedure of the gradient elution is as follows:

[0033] 0 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 95:5;

[0034] 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 95:5;

[0035] 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0036] 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0037] 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85:15;

[0038] 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 95:5;

[0039] 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 95:5.

[0040] Furthermore, the concentration of the mobile phase A is 0.01-0.03 mol / L, and the pH is 3.0-3.5; preferably, the concentration of the mobile phase A is 0.02 mol / L, and the pH is 3.2-3.4; the most preferred pH is 3.3.

[0041] Furthermore, the flow rate of the fluidity is 1.4-1.6 ml / min, preferably 1.5 ml / min; the column temperature of the chromatographic column is 43-47°C, preferably 45°C.

[0042] Preferably, the injection volume is 20 μl.

[0043] Preferably, the chromatographic column is Agilent ZORBAX SB-C18, with specifications of 4.6 mm×250 mm and 5 μm.

[0044] Preferably, the run time is 50 minutes.

[0045] The second object of the present invention is to provide a method for identifying impurities in a calcium folinate intermediate Z2, which can detect impurities with a content of 0.01% in the calcium folinate intermediate Z2 with a low detection limit.

[0046] To achieve the above object, the present invention adopts the following technical solutions:

[0047] Method for identifying impurities in calcium folinate intermediate Z2, wherein the impurities include the impurity A, the impurity Z1, the impurity Z2 2b Any one or more of the above; the method comprises: using the above method to separate the calcium folinate intermediate Z2 and its impurities; entering the detector for detection to obtain a chromatogram; comparing the chromatogram of the test product with the chromatogram of the known reference product to determine whether the test product contains the impurity A, impurity Z1, impurity Z 2b Any one or more of .

[0048] Furthermore, the detection wavelength of the detector is 300±10 nm; preferably, the detection wavelength is 300 nm.

[0049] Furthermore, the retention time of each component from short to long is: impurity A, impurity Z1, impurity Z 2b , calcium folinate intermediate Z2, calcium folinate.

[0050] Each component can be qualitatively identified based on its retention time.

[0051] Further, taking the calcium folinate intermediate Z2 as the reference peak, the relative retention time was 0.34±0.02, which was determined to be impurity A; the relative retention time was 0.67±0.02, which was determined to be impurity Z1; the relative retention time was 0.88±0.02, which was determined to be impurity Z 2b .

[0052] Further, when the retention time was 7.3±0.5min, it was determined to be impurity A; when the retention time was 14.3±0.5min, it was determined to be impurity Z1; when the retention time was 19.0±0.5min, it was determined to be impurity Z 2b ; When the retention time was 21.8±0.5min, it was determined to be the calcium folinate intermediate Z2.

[0053] The third object of the present invention is to provide a method for determining the impurity content in the calcium folinate intermediate Z2, which can effectively determine the impurity content of 0.02% in the calcium folinate intermediate Z2, with low quantitative limit and high sensitivity.

[0054] To achieve the above object, the present invention adopts the following technical solutions:

[0055] Method for determining the impurity content in the calcium folinate intermediate Z2, wherein the impurities include the impurity A, the impurity Z1, the impurity Z 2b Any one or more of; the method comprises the following steps:

[0056] (1) Separating and detecting the calcium folinate intermediate Z2 and its impurities using the aforementioned method to obtain a chromatogram;

[0057] (2) According to the chromatogram measured in step (1), the content of the calcium folinate intermediate Z2 and its impurities is calculated by using the area normalization method.

[0058] Furthermore, a combination of acetonitrile, water and mercaptoethanol is used as a sample preparation solvent, wherein the volume ratio of acetonitrile, water and mercaptoethanol is 90-110:890-910:8-12.

[0059] Preferably, in the solvent, the volume ratio of acetonitrile, water and mercaptoethanol is 100:900:10.

[0060] Furthermore, the concentration of the test solution was 2.0 mg / ml.

[0061] Preferably, the following chromatographic conditions are used for determination: the chromatographic column uses octadecylsilane bonded silica gel as a filler, the chromatographic column specifications are 4.6 mm×250 mm, 5 μm; the mobile phase A is a phosphate buffer with a concentration of 0.02 mol / L and a pH of 3.2-3.4, and the mobile phase B is methanol; the flow rate is 1.4-1.6 ml / min, and the column temperature is 43-47° C.; the detection wavelength is 300 nm; the following gradient elution program is used for elution and a chromatogram is obtained:

[0062] 0 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0063] 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0064] 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0065] 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10;

[0066] 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85:15;

[0067] 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5;

[0068] 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5.

[0069] Preferably, the determination method comprises the following steps:

[0070] 1. Take an appropriate amount of this product, weigh it accurately, add diluent to dissolve it, and then add an equal volume of water to dilute it to a solution with a concentration of 2.0 mg / ml as the sample solution;

[0071] 2. Take calcium folinate intermediate Z2, impurity A, impurity Z 2b , impurity Z1 and left calcium folinate reference substance, add diluent to dissolve, then add an equal volume of water to dilute to make each ml contain about impurity A, impurity Z 2b , Z1 and calcium folinate 10 μg each and Z2 about 2.0 mg solution as system suitability solution;

[0072] 3. Take the above system suitability solution and sample solution, such as 20 μl, respectively, and inject them into the liquid chromatograph for detection to obtain a chromatogram; calculate the content of each impurity by peak area normalization method.

[0073] The beneficial effects of the present invention are:

[0074] 1. The method of the present invention can achieve the removal of impurities A, impurities Z1 and impurities Z2 in the calcium folinate intermediate Z2. 2b The effective determination of impurities A, Z1, Z2 and other single impurities in the calcium folinate intermediate Z2 can be carried out in 50 minutes. 2b , and left calcium folinate are separated simultaneously, with the characteristic of short separation time.

[0075] 2. The self-built high performance liquid chromatography method of the present invention can effectively detect the impurities at a level of 0.01% in the calcium folinate intermediate Z2, and can effectively quantify the impurities at a level of 0.02% in the calcium folinate intermediate Z2. The method has high sensitivity.

[0076] 3. The present invention adopts gradient elution high performance liquid chromatography, the buffer salt uses simple phosphate, the organic phase uses methanol, and the chromatographic column uses the SB-C18 column of conventional octadecylsilane bonded silica gel as filler, and the related substances of the left calcium folinate intermediate Z2 are determined, and the detection is carried out by this chromatographic condition, so that the main component peak type is relatively symmetrical, and each impurity can be effectively separated to obtain an accurate impurity content. This method is simple, has strong specificity, high sensitivity, and good reproducibility. And the method of the present invention can adopt a simple area normalization method to measure and calculate ionic compounds, thereby ensuring that the quality of left calcium folinate is controllable, and finally determining the safety and effectiveness of the product, which is of great significance for the quality control of left calcium folinate. BRIEF DESCRIPTION OF THE DRAWINGS

[0077] Figure 1 is the chromatogram of the blank solution in Example 2;

[0078] Figure 2 is a chromatogram of the impurity Z1 localization solution in Example 2;

[0079] Figure 3 is a chromatogram of the impurity A localization solution in Example 2;

[0080] Figure 4 is the impurity Z in Example 2 2b Chromatogram of the positioning solution;

[0081] Figure 5 The chromatogram of the left calcium folinate localization solution in Example 2;

[0082] Figure 6 is the chromatogram of the mixed solution in Example 2;

[0083] Figure 7 is the chromatogram of the quantitative limit solution in Example 4;

[0084] Figure 8 is the chromatogram of the detection limit solution in Example 4;

[0085] Fig. 9 is a chromatogram of the mixed solution in Example 3 under normal conditions;

[0086] Fig.10 is a chromatogram of the mixed solution in Example 3 at pH 3.4;

[0087] Fig.11 is a chromatogram of the mixed solution in Example 3 at pH 3.2;

[0088] Fig.12 The chromatogram of the mixed solution in Example 3 at a flow rate of 1.6 ml / min;

[0089] Fig.13 This is the chromatogram of the mixed solution in Example 3 at a flow rate of 1.4 ml / min;

[0090] Fig.14 The chromatogram of the mixed solution in Example 3 under the condition of the initial ratio of the mobile phase A:B=94.5:5.5;

[0091] Fig.15 The chromatogram of the mixed solution in Example 3 under the condition of the initial ratio of the mobile phase A:B=95.5:4.5;

[0092] Fig.16 This is the chromatogram of the mixed solution in Example 3 at a column temperature of 43°C;

[0093] Fig.17 The chromatogram of the mixed solution in Example 3 at a column temperature of 47°C. DETAILED DESCRIPTION

[0094] The technical solution of the present invention will be further described clearly and completely in conjunction with specific embodiments below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all the embodiments. Therefore, based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work belong to the protection scope of the present invention.

[0095] In the examples of the present invention, the compound information involved is as follows:

[0096] Calcium folinate intermediate Z2: Chinese chemical name: (6aR)-3-amino-8-[4-[[(2S)-1,3-dicarboxypropyl]carbamoyl]phenyl]-1-oxo-2,5,6,6a,7,8-octahydro-1H-imidazo[1,5-f]pteridine-10-chloride, molecular formula: C 20 H 22 ClN7O6, molecular weight is 528.35, structural formula is shown in formula Ⅰ;

[0097]

[0098] Calcium folinate: Chinese chemical name is N-[4-[(6S)-(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pterydinyl)methyl]amino]benzoyl-L-glutamic acid calcium salt hydrate; molecular formula is C 20 H 21 CaN7O7, XH2O, molecular weight is 511.5 (anhydrous), structural formula is shown in formula II;

[0099]

[0100] Impurity Z1: Chinese chemical name is (2S)-2-(4-((((6S)-2-amino-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)glutaric acid, molecular formula is C 19 H 23 N7O6, molecular weight is 445.43, and the structural formula is shown in Formula III;

[0101]

[0102] Impurity A(SM 1a ): The Chinese chemical name is (2S)-2-(4-aminobenzoyl)glutaric acid, and the molecular formula is: C 12 H 14 N2O5, molecular weight is 266.25, structural formula is shown in formula IV;

[0103]

[0104] Impurity Z 2b :The Chinese chemical name is (6a R)-3-amino-8-(4-carboxyphenyl)-1-oxo-2,5,6,6a,7,8-hexahydro-1H-imidazo[1,5-f]pteridine-10-chloride, and the molecular formula is C 15 H 15 ClN6O3, molecular weight 399.23, structural formula as shown in formula V;

[0105]

[0106] In the embodiment of the present invention, the impurity calcium folinate is the next product and is only used for specific positioning in this system. Calcium folinate is integrated but not included in the single impurity and total impurities.

[0107] In the embodiment of the present invention, the calcium ions of the impurity calcium folinate (impurity Z3 represents crude calcium folinate) are released in the liquid phase system, and there is no response signal, and only the folinic acid group part responds, so only the response signal of folinic acid is finally measured.

[0108] Example 1. Separation and determination of calcium folinate intermediate Z2 and its related impurities by HPLC

[0109] (1) Chromatographic conditions: as shown in Table 1.

[0110] Table 1. Chromatographic conditions

[0111]

[0112] Table 2. Gradient elution program

[0113] Time (minutes) Mobile phase A (%) Mobile phase B (%) 0 95 5 8 95 5 20 90 10 38 90 10 42 85 15 42.1 95 5 50 95 5

[0114] (2) Solution preparation

[0115] Blank solvent: acetonitrile-water-mercaptoethanol (50:950:5).

[0116] Diluent: acetonitrile-water-mercaptoethanol (100:900:10).

[0117] Test solution: Take an appropriate amount of the product, weigh it accurately, add diluent to dissolve it, and then add an equal volume of water to dilute it to make a solution containing about 2 mg per 1 ml as the test solution.

[0118] System suitability solution: Take calcium folinate intermediate Z2, impurity A, impurity Z 2b , impurity Z1 and left calcium folinate reference substance, add diluent to dissolve, then add an equal volume of water to dilute to make each ml contain about impurity A, impurity Z 2b A solution of 10 μg each of Z1 and left calcium folinate and about 2.0 mg of Z2 was used as the system suitability solution.

[0119] (3) Test method

[0120] Accurately measure 20 μl of the system suitability solution, inject it into the liquid chromatograph, and record the chromatogram. The peak order is impurity A, impurity Z1, impurity Z 2b , intermediate Z2, calcium folinate, impurity Z 2b The separation between Z2 should be no less than 1.5.

[0121] Accurately measure 20 μl of the test solution, inject it into the liquid chromatograph, and record the chromatogram.

[0122] If there are impurity peaks in the chromatogram of the test solution, except for the solvent peak and gradient peak, the impurity A shall not exceed 1.0%, the impurity Z1 shall not exceed 0.2%, and the impurity Z 2b The content of calcium folinate shall not exceed 0.5%, other individual impurities shall not exceed 1.0%, the total amount of impurities shall not exceed 5.0%, and the content of the main component shall not be less than 95.0%. Calcium folinate is integral but not included in individual impurities and total impurities.

[0123] Example 2. Specificity experiment

[0124] 1. Prepare the test solution

[0125] Diluent: acetonitrile-water-mercaptoethanol (100:900:10);

[0126] Impurity A stock solution: Accurately weigh 2.66 mg of impurity A, place in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and obtain.

[0127] Impurity Z2b Stock solution: Accurately weigh impurity Z 2b 2.60 mg, put in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and you have it.

[0128] Impurity Z1 stock solution: Accurately weigh 2.62 mg of Z1 test sample, place in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and obtain.

[0129] Calcium folinate localization solution: Accurately weigh 2.47 mg of calcium folinate test sample, place in a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, transfer 1 ml to a 10 ml volumetric flask, add diluent to dilute to the scale, shake well, and obtain.

[0130] Test sample solution: Accurately weigh about 100 mg of Z2 test sample (batch number: LCAC-P-Z2-190701) and place it in a 50 ml volumetric flask. Add diluent to dissolve it, and then add an equal volume of water to dilute it to make a solution containing about 2 mg per 1 ml. This is the test sample solution.

[0131] Mixed solution: Accurately weigh 101.66 mg of Z2 test sample and place it in a 50 ml volumetric flask. Accurately pipette impurities A, Z1, and Z2 into the mixture. 2b Place 1.0 ml of each stock solution in the same volumetric flask as above, add diluent to dissolve it, then add an equal volume of water to dilute it to make a solution containing about 2 mg per 1 ml, shake well, and you have it.

[0132] Impurity A, Impurity Z1, Impurity Z 2b Positioning solution: Take impurity A, impurity Z1, impurity Z respectively 2b Pour 1.0 ml of each stock solution into a 10 ml volumetric flask, add diluent to dissolve and dilute to the scale, shake well, and you are done.

[0133] 2. Detection

[0134] Take 20 μl of the above diluent, each impurity localization solution, test solution, and mixed solution respectively, inject according to the method, and the chromatographic conditions are the same as those in Example 1; record the chromatogram.

[0135] Results: The results of the specificity test are shown in Table 3. Figure 1-Figure 6 , Figure 6 The integration results are shown in Table 4. The blank solvent had no interference with the test sample detection, the separation between each impurity peak was greater than 1.5, the separation between the main peak and the adjacent impurity was 3.24, the main peak theoretical plate number was 11375, greater than 5000; the main peak tailing factor was 1.07, less than 1.5, and the specificity was good.

[0136] Table 3. Specificity test results

[0137]

[0138] Table 4. Figure 6 The integral results table

[0139]

[0140] Example 3. Durability test

[0141] Take a mixed solution (the preparation method is the same as that of the mixed solution under the specificity item in Example 2, prepared before use), and use normal mobile phase, different mobile phase initial ratios, mobile phase pH, column temperature, column flow rate and chromatographic columns of the same model but different batches for testing. After the instrument system is stable, test them separately and record the separation degree and relative retention time between each peak.

[0142] The test results are shown in Table 5. Figure 9-Figure 17 , Figure 9-Figure 17 The integration results are shown in Tables 6 to 14. When the flow rate, column temperature, mobile phase pH and initial ratio of the mobile phase fluctuate and when the chromatographic columns of the same model but different batches are replaced, the separation between the main peak and each known impurity is greater than 1.5, indicating that the chromatographic conditions of this method are durable.

[0143] Table 5. Durability test results

[0144]

[0145] Table 6. Fig. 9 The integral results table

[0146]

[0147] Table 7. Fig.10 The integral results table

[0148]

[0149] Table 8. Fig.11 The integral results table

[0150]

[0151]

[0152] Table 9. Fig.12 The integral results table

[0153]

[0154] Table 10. Fig.13 The integral results table

[0155]

[0156] Table 11. Fig.14 The integral results table

[0157]

[0158] Table 12. Fig.15 The integral results table

[0159]

[0160]

[0161] Table 13. Fig.16 The integral results table

[0162]

[0163] Table 14. Fig.17 The integral results table

[0164]

[0165] Example 4. Limit of Quantitation and Limit of Detection Test

[0166] Quantitation limit solution: Accurately weigh 1.197 mg of impurity A reference substance, 1.133 mg of Z1 reference substance, and 1.113 mg of impurity Z 2b The reference substance and 1.041 mg Z2 reference substance were placed in the same 50 ml volumetric flask, diluted to the mark after adding the diluent and ultrasonically dissolving, and shaken well. Then 1 ml of the above solution was transferred to a 50 ml volumetric flask, diluted to the mark after adding the diluent and ultrasonically dissolving, and shaken well to prepare a quantitative limit test solution with each impurity and Z2 content of 0.02%.

[0167] Detection limit solution: Accurately weigh 0.925 mg of impurity A reference substance, 1.047 mg of Z1 reference substance, and 1.010 mg of impurity Z 2b The reference substance and 1.161 mg Z2 reference substance were placed in the same 100 ml volumetric flask, diluted to the mark after adding the diluent and ultrasonically dissolving, and shaken well. Then 1 ml of the above solution was transferred to a 50 ml volumetric flask, diluted to the mark after adding the diluent and ultrasonically dissolving, and shaken well to prepare a detection limit test solution with each impurity and Z2 content of 0.01%.

[0168] The quantitative limit solution and the detection limit solution were injected three times respectively, and the detection was performed according to the chromatographic conditions of Example 1. The chromatogram was recorded, and the ratio of the main peak height to the noise (signal-to-noise ratio) was calculated.

[0169] The test results are shown in Table 15. Figure 7-Figure 8 , Figure 7-Figure 8The integration results are shown in Tables 16 and 17. The quantification limit of Z2 is 0.383 μg / ml; the quantification limit of impurity A is 0.408 μg / ml, which is 0.020% based on the concentration in Z2; the quantification limit of Z1 is 0.386 μg / ml, which is 0.019% based on the concentration in Z2; 2b The quantitative limit concentration is 0.414μg / ml, which is expressed as 0.021% in Z2; the signal-to-noise ratio of each impurity and Z2 is greater than 10, indicating that each impurity can be quantitatively detected at the 0.02% level.

[0170] The detection limit concentration of Z2 is 0.214μg / ml; the detection limit concentration of impurity A is 0.158μg / ml, which is 0.008% based on the concentration in Z2; the detection limit concentration of Z1 is 0.179μg / ml, which is 0.009% based on the concentration in Z2; 2b The detection limit concentration is 0.188μg / ml, which is expressed as 0.009% in Z2; the signal-to-noise ratio of each impurity and Z2 is greater than 3, indicating that each impurity can be effectively detected at the 0.01% level.

[0171] Table 15. Quantitation limit and detection limit test results

[0172]

[0173] Table 16. Figure 7 The integral results table

[0174]

[0175]

[0176] Table 17. Figure 8 The integral results table

[0177]

Claims

1. A method for separating the calcium folinate intermediate Z2 and its impurities by HPLC, characterized in that: The impurities include impurity A, impurity Z1, impurity Z 2b , any one or more of calcium folinate; the chromatographic column of the HPLC method uses octadecylsilane bonded silica gel as a filler, and the mobile phase includes a mobile phase A and a mobile phase B, the mobile phase A is a phosphate buffer, and the mobile phase B is methanol; Impurity A, impurity Z1, impurity Z1, etc. were removed in turn by gradient elution. 2b , separating the left calcium folinate intermediate Z2 and / or left calcium folinate; The structural formula of the calcium folinate intermediate Z2 is shown in Formula I, the structural formula of the calcium folinate is shown in Formula II, the structural formula of the impurity Z1 is shown in Formula III, the structural formula of the impurity A is shown in Formula IV, and the impurity Z 2b The structural formula is shown in Formula V; 2. The method according to claim 1, characterized in that: The procedure of the gradient elution is as follows: 0 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2; 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2; 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85-95:15-5; 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85-95:15-5; 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 80-90:20-10; 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2; 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 92-98:8-2.

3. The method according to claim 1, characterized in that The concentration of the mobile phase A is 0.01-0.03 mol / L, and the pH is 3.0-3.

5.

4. The method according to claim 1, characterized in that: The flow rate of the fluidity is 1.4-1.6 ml / min, and the column temperature of the chromatographic column is 43-47°C.

5. A method for identifying impurities in the calcium folinate intermediate Z2, characterized in that: The impurities include the impurity A, the impurity Z1, the impurity Z 2b any one or more of; the method comprises: separating the calcium folinate intermediate Z2 and its impurities by the method according to any one of claims 1 to 4; entering the detector for detection to obtain a chromatogram; comparing the chromatogram of the test product with the chromatogram of a known reference product to determine whether the test product contains the impurities A, impurity Z1, impurity Z 2b Any one or more of .

6. The method according to claim 5, characterized in that The detection wavelength of the detector is 300±10 nm.

7. The method according to claim 5, characterized in that Taking the left calcium folinate intermediate Z2 as the reference peak, the relative retention time was 0.34±0.02, which was determined to be impurity A; the relative retention time was 0.67±0.02, which was determined to be impurity Z1; the relative retention time was 0.88±0.02, which was determined to be impurity Z 2b .

8. A method for determining the impurity content in the calcium folinate intermediate Z2, characterized in that: The impurities include the impurity A, the impurity Z1, the impurity Z 2b Any one or more of; the method comprises the following steps: (1) separating and detecting the calcium folinate intermediate Z2 and its impurities using the method described in any one of claims 5 to 7 to obtain a chromatogram; (2) According to the chromatogram measured in step (1), the content of the calcium folinate intermediate Z2 and its impurities is calculated by using the area normalization method.

9. The method according to claim 8, characterized in that A combination of acetonitrile, water and mercaptoethanol is used as a sample preparation solvent, wherein the volume ratio of acetonitrile, water and mercaptoethanol is 90-110:890-910:8-12.

10. The method according to claim 8, characterized in that The following chromatographic conditions were used for determination: the chromatographic column used octadecylsilane bonded silica gel as a filler, the chromatographic column specifications were 4.6 mm×250 mm, 5 μm; the mobile phase A was a phosphate buffer with a concentration of 0.02 mol / L and a pH of 3.2-3.4, and the mobile phase B was methanol; the flow rate was 1.4-1.6 ml / min, and the column temperature was 43-47° C.; the detection wavelength was 300 nm; the following gradient elution program was used for elution and a chromatogram was obtained: 0 minutes, and the volume ratio of the mobile phase A to the mobile phase B was set to 94.5-95.5:5.5-4.5; 8 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5; 20 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10; 38 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 90:10; 42 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 85:15; 42.1 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5; 50 minutes, setting the volume ratio of the mobile phase A to the mobile phase B to 94.5-95.5:5.5-4.5.